Immune checkpoint inhibitors as therapy to down-stage hepatocellular carcinoma prior to liver transplantation

HIGHLIGHTS

  • who: Nitin N. Katariya and collaborators from the Department of Surgery, Division of Transplant and HPB Surgery, Alix School of Medicine, Department of Surgery, Division of Transplantation, University of Arkansas for Medical Sciences have published the paper: Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation, in the Journal: Cancers 2022, 2056 of 29/04/2021
  • what: Treatment-related death occurs in up to 2% of those being treated 6 of 17 7 of 17 data from this trial showed similar safety in Child`s B patients as in a . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?